THE MOUSE C-REACTIVE PROTEIN (CRP) GENE IS EXPRESSED IN RESPONSE TO IL-1 BUT NOT IL-6

被引:20
|
作者
KU, NO [1 ]
MORTENSEN, RF [1 ]
机构
[1] OHIO STATE UNIV, DEPT MICROBIOL, 484 W 12TH AVE, COLUMBUS, OH 43210 USA
关键词
C-REACTIVE PROTEIN; SERUM AMYLOID P-COMPONENT; ACUTE PHASE REACTANT;
D O I
10.1016/1043-4666(93)90063-B
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C-Reactive protein (CRP) is a minor acute phase reactant (APR) in the mouse, whereas CRP is the prototypical and one of the major positive APRs in all other mammals. MoCRP gene expression was tissue specific for the liver and induced by culture supernatants of LPS-activated macrophages. MoCRP gene expression by isolated hepatocytes in culture increased c. 3-fold in response to interleukin (IL)-1, but not IL-6. IL-6 is the most potent inflammatory cytokine for the induction of human CRP and many other APRs. By contrast, gene expression of the major APR of the mouse, serum amyloid P-component (SAP), a structural homologue of CRP, increased in response to either IL-1 or IL-6 under the same conditions. The region containing two potentially IL*1 responsive C/EBP elements in the moCRP gene failed to respond to IL-1 when a pCAT contstruct containing the elements was transfected into Hep 3B2 hepatoma cells. Therefore, IL-1 may influence the expression of the moCRP gene at the post-transcriptional rather than at the transcriptional level. The findings suggest that moCRP may be a minor APR because of the limited response of the gene to inflammatory cytokine signals. © 1993 Academie Press Limited.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 50 条
  • [41] Influence of CRP, IL6, and TNFA Gene Polymorphisms on Circulating Levels of C-Reactive Protein in Mexican Adolescents
    Mendoza-Carrera, Francisco
    Ramirez-Lopez, Guadalupe
    Angelica Ayala-Martinez, Norma
    Guadalupe Garcia-Zapien, Alejandra
    Esperanza Flores-Martinez, Silvia
    Sanchez-Corona, Jose
    ARCHIVES OF MEDICAL RESEARCH, 2010, 41 (06) : 472 - 477
  • [42] CRP, IL-1α, IL-1β, and IL-6 levels and the risk of breast cancer: a two-sample Mendelian randomization study
    Cui, Yongjia
    Cui, Shasha
    Lu, Wenping
    Wang, Ya'nan
    Zhuo, Zhili
    Wang, Ruipeng
    Zhang, Dongni
    Wu, Xiaoqing
    Chang, Lei
    Zuo, Xi
    Zhang, Weixuan
    Mei, Heting
    Zhang, Mengfan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [44] Lower C-reactive protein and IL-6 associated with vegetarian diets are mediated by BMI
    Jaceldo-Siegl, K.
    Haddad, E.
    Knutsen, S.
    Fan, J.
    Lloren, J.
    Bellinger, D.
    Fraser, G. E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (08) : 787 - 794
  • [45] CRP, IL-1α, IL-1β, and IL-6 levels and the risk of breast cancer: a two-sample Mendelian randomization study
    Yongjia Cui
    Shasha Cui
    Wenping Lu
    Ya’nan Wang
    Zhili Zhuo
    Ruipeng Wang
    Dongni Zhang
    Xiaoqing Wu
    Lei Chang
    Xi Zuo
    Weixuan Zhang
    Heting Mei
    Mengfan Zhang
    Scientific Reports, 14
  • [46] 爆炸伤创面IL-1、IL-6、TNF-α、CRP的测定
    王玮
    张雪非
    中国矫形外科杂志, 2007, (18) : 1418 - 1420
  • [47] C-reactive protein and IL-6:: new marker proteins for the diagnosis of CJD in plasma?
    Völkel, D
    Zimmermann, K
    Zerr, I
    Lindner, T
    Bodemer, M
    Poser, S
    Schwarz, HP
    TRANSFUSION, 2001, 41 (12) : 1509 - 1514
  • [48] IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms*
    Ngwa, Donald N.
    Pathak, Asmita
    Agrawal, Alok
    MOLECULAR IMMUNOLOGY, 2022, 146 : 50 - 56
  • [49] Relationship between Vitreous IL-6 Levels, Gender Differences and C-Reactive Protein (CRP) in a Blood Sample of Posterior Uveitis
    Sakai, Atsushi
    Tagami, Mizuki
    Katsuyama-Yoshikawa, Atsuko
    Misawa, Norihiko
    Haruna, Yusuke
    Azumi, Atsushi
    Honda, Shigeru
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [50] Associations of IL-1β and IL-6 gene polymorphisms with Parkinson's disease
    Li, N.
    Wang, J-X
    Huo, T-T
    Zhao, J-R
    Wang, T. J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (02) : 890 - 897